Amicus Releases More Impressive Pompe Disease Data at WORLDSymposium
The company presented a late-breaker poster and corresponding oral presentation at the conference. Source: BioSpace
The company presented a late-breaker poster and corresponding oral presentation at the conference. Source: BioSpace
The FDA approved Gilead's triple combination treatment for HIV, Biktarvy. Source: BioSpace
Here is some insight on what Vertex may be looking for in their employees. Source: BioSpace
Sponsors of systemic antibacterial drugs should evaluate their products against test panels of relevant bacteria and against approved drugs with similar mechanisms of activity, the FDA said, in a newly…
API manufacturer Macfarlan Smith drew a Form 483 from the FDA for failing to ensure products manufactured at its Edinburgh, Scotland facility met current good manufacturing practice requirements. Source: Drug…
A group of non-profits and activist organizations, including the American Lung Association, National Health Council and National Organization for Rare Disorders, urged lawmakers in the House of Representatives not to…
The FDA released new information for ANDA applicants on when to submit elemental impurity data, and acknowledged that new guidelines on reporting elemental impurities had slowed approvals in January. Source:…
Joseph E. Payne was shown the door as CEO of Arcturus last week - a move that Payne is not taking lightly. Source: BioSpace
Since Friday, the stock market has been volatile, to say the least. Source: BioSpace
This is the second Breakthrough Therapy designation granted to Sage since 2016. Source: BioSpace